Health

New Rule Seeks to Expand Medicare and Medicaid Coverage of Weight Loss Drugs.

The future of gender-affirming care may turn on the definition of “sex discrimination” in the Affordable Care Act.

Political pressure and wary regulators shaped FDA’s mifepristone approval in 2000.

Scholar proposes an increased focus on children’s health in food, drug, and cosmetic regulation.

An upcoming U.S. Supreme Court case may change the landscape of gender-affirming care regulations.

David Peloquin discusses the development and future directions of clinical research regulations.

Jeffrey Michael discusses the roles of research, technology, and community engagement in shaping transportation policy.

Scholars debate ways to improve FDA’s accelerated approval mechanism.

Scholar argues that patents do not—and should not—compensate for the costs of drug development.

Policymakers debate whether to use federal health care funding to cover nutrition programs.

Scholar argues that OSHA has the authority to regulate occupational heat exposure.

Scholar calls for regulators to correct the dangers of inadequate cosmetics regulations for women of color.